[1] 刘晓丹,严隽陶,胡军. 当代康复学科科研发展趋势分析[J]. 中国康复理论与实践, 2012, 18(10): 969-971. [2] 吴蓉,董冰媛,刘一洋. 医学论文文稿撰写中的质量问题及改进意见[J]. 实用医药杂志, 2017, 34(7): 664-666. [3] Laba J M, Senan S, Schellenberg D, et al. Identifying barriers to accrual in radiation oncology randomized trials [J]. Curr Oncol, 2017, 24(6): e524-e530. [4] 吴泰相,李幼平,李静,等. 中国临床试验注册和发表机制及实施说明[J]. 中国康复理论与实践, 2006, 12(9): 778-779. [5] Gray R, Badnapurkar A, Hassanein E, et al. Registration of randomized controlled trials in nursing journals [J]. Res Integr Peer Rev, 2017, 2(1): 8. [6] 杜亮,李幼平,张永刚. 强化两端,健全高质量证据生产的全程质控[J]. 中国循证医学杂志, 2017, 17(11): 1241-1244. [7] Viergever R F, Li K. Trends in global clinical trial registration: an analysis of numbers of registered clinical trials in different parts of the world from 2004 to 2013 [J]. BMJ Open, 2015, 5(9): e008932. [8] 邬兰,田国祥,王行环,等. 临床试验的注册及注册平台比较分析[J]. 中国循证心血管医学杂志, 2017, 9(2): 129-134. [9] 耿朝辉,袁长蓉. 构建移动医疗领域健康行为干预模式的常用理论框架[J]. 解放军护理杂志, 2016, 33(3): 43-48. [10] Lewis F M,张娜芹,刘均娥,等. 设计以证据为基础的干预:从描述性研究到临床实验研究[J]. 中国护理管理, 2016, 16(8): 1013-1017. [11] Yamato T, Maher C, Saragiotto B, et al. Improving completeness and transparency of reporting in clinical trials using the template for intervention description and replication (TIDieR) checklist will benefit the physiotherapy profession [J]. J Man Manip Ther, 2016, 24(4): 183-184. [12] Bacon S L, Lavoie K L, Ninot G, et al. An international perspective on improving the quality and potential of behavioral clinical trials [J]. Curr Cardiovascul Risk Rep, 2015, 9(1): 1-6. [13] Chan A W, Tetzlaff J M, Altman D G, et al. SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials [J]. Ann Intern Med, 2013, 158(3): 200-207. [14] Schulz K F, Altman D G, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials [J]. Int J Surg, 2011, 9(8): 672-677. [15] Daykin A, Clement C, Gamble C, et al. ‘Recruitment, recruitment, recruitment’ - the need for more focus on retention: a qualitative study of five trials [J]. Trials, 2018, 19(1): 76. [16] Fletcher B, Gheorghe A, Moore D, et al. Improving the recruitment activity of clinicians in randomised controlled trials: a systematic review [J]. BMJ Open, 2012, 2(1): e000496. [17] Spaar A, Frey M, Turk A, et al. Recruitment barriers in a randomized controlled trial from the physicians' perspective-a postal survey [J]. BMC Med Res Methodol, 2009, 9(1): 14. [18] Mills E J, Seely D, Rachlis B, et al. Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors [J]. Lancet Oncol, 2006, 7(2): 141-148. [19] Briel M, Olu K K,Von E E, et al. A systematic review of discontinued trials suggested that most reasons for recruitment failure were preventable [J]. J Clin Epidemiol, 2016, 80: 8-15. [20] Alba R, Ann A, Peter W, et al. A new simple six-step model to promote recruitment to RCTs was developed and successfully implemented [J]. J Clin Epidemiol, 2016, 76: 166-174. [21] Mills N, Blazeby J M, Hamdy F C, et al. Training recruiters to randomized trials to facilitate recruitment and informed consent by exploring patients' treatment preferences [J]. Trials, 2014, 15(1): 323. [22] Wilson C, Rooshenas L, Paramasivan S, et al. Development of a framework to improve the process of recruitment to randomised controlled trials (RCTs): the SEAR (Screened, Eligible, Approached, Randomised) framework [J]. Trials, 2018, 19(1): 50. [23] Ailish H, Mary O, Byrne M C, et al. Identifying strategies to maximise recruitment and retention of practices and patients in a multicentre randomised controlled trial of an intervention to optimise secondary prevention for coronary heart disease in primary care [J]. BMC Med Res Methodol, 2009, 9(1): 40. [24] Mars T, Ellard D, Carnes D, et al. Fidelity in complex behavior change interventions: a standardised approach to evaluate intervention integrity [J]. BMJ Open, 2013, 3(11): e003555. [25] Bellg A J, Borrelli B, Resnick B, et al. Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium [J]. Health Psychol, 2004, 23(5): 443-451. [26] Spillane V, Byrne M C, Byrne M, et al. Monitoring treatment fidelity in a randomized controlled trial of a complex intervention [J]. J Adv Nurs, 2007, 60(3): 343-352. [27] Morgan P P. Compliance in health care [J]. Can Med Assoc J, 1979, 121(11): 1495. [28] El Feky A, Gillies K, Gardner H, et al. A protocol for a systematic review of non-randomised evaluations of strategies to increase participant retention to randomised controlled trials [J]. Syst Rev, 2018, 7(1): 30. [29] Brueton V C, Tierney J F, Stenning S, et al. Strategies to improve retention in randomised trials: a Cochrane systematic review and meta-analysis [J]. BMJ Open, 2014, 4(2): e003821. [30] Booker C L, Harding S, Benzeval M. A systematic review of the effect of retention methods in population-based cohort studies [J]. BMC Public Health, 2011, 11(1): 1-12. [31] Abshire M, Dinglas V D, Cajita M I A, et al. Participant retention practices in longitudinal clinical research studies with high retention rates [J]. BMC Med Res Methodol, 2017, 17(1): 30. [32] Donabedian A. The quality of care. How can it be assessed? 1988 [J]. Arch Pathol Lab Med, 1997, 121(11): 1145-1150. [33] 邱瑞瑾,孙杨,胡嘉元,等. 临床研究中选择结局指标测量工具的方法[J]. 中国循证医学杂志, 2018, 18(2): 238-243. [34] 赵玉婷. 临床试验数据管理常见问题类型分析方法的建立[D]. 上海:复旦大学, 2012. [35] Hussain J A, White I R, Langan D, et al. Missing data in randomised controlled trials testing palliative interventions pose a significant risk of bias and loss of power: a systematic review and meta-analyses [J]. J Clin Epidemiol, 2015, 74: 57-65.
|